R&N Determination | Low Risk

Is Saxagliptin Reasonable and Necessary?

Reasonable and Necessary determination guidance for Saxagliptin (Onglyza) on workers compensation and personal injury claims.

R&N Guide Source: PBS, TGA Updated April 2026

Whether Saxagliptin (Onglyza) is reasonable and necessary depends on the compensable injury, prescribing duration, and clinical justification. Saxagliptin is classified as Low risk by AllMeds. It is S4 under the TGA in Australia. Claims professionals should assess whether the prescribing is directly related to the injury, within clinical guidelines for duration and dose, and not for a pre-existing condition.

Key Takeaways

  • Risk level: Low (1 points)
  • Schedule: S4 in Australia
  • Key question: Is Saxagliptin being prescribed for the compensable injury, or for a pre-existing or unrelated condition?

R&N Assessment: When Is Saxagliptin Injury-Related?

Possibly Related - Requires Clinical Justification

  • Conditions that may be partially related to or aggravated by the injury

Likely Not Reasonable and Necessary

  • Pre-existing conditions managed before the injury occurred
  • Conditions with no clinical link to the compensable event

How to Make the R&N Determination

  1. Check injury relatedness: Is Saxagliptin being prescribed for the compensable injury, or for a pre-existing or unrelated condition?
  2. Review clinical justification: Does the treating doctor's documentation explain why Saxagliptin is necessary for this specific injury?
  3. Assess duration: Is the prescribing duration within clinical guidelines?
  4. Check for alternatives: Have safer or more appropriate treatments been trialled first?
  5. Review interactions: Is Saxagliptin being combined with other medications that create additional risk?
  6. Document your determination: Record the R&N decision, rationale, and any actions taken in the claim file.

Need to assess this medication across your caseload?

Run an automated R&N determination for Saxagliptin against the compensable injury. AllMeds scores every medication as directly related, possibly related, or unrelated.

AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.

No credit card required. No signup for your first 2 questions.

Related Resources

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.